课题基金 / 基金详情

T 20 ADMINISTERED TO HIV 1 ADULTS BY CONTINUOUS SUBCUTANEOUS INFUSION

T 20 ADMINISTERED TO HIV 1 ADULTS BY CONTINUOUS SUBCUTANEOUS INFUSION
T 20 通过持续皮下输注对 HIV 1 成人进行给药
批准号：
6303924
负责人：
Joseph J Eron
金额：
$0.02万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
项目状态：
已结题
起止时间：
1999-12-01 至 2000-11-30
来源：
https://reporter.nih.gov/project-details/6303924
关键词：
AIDS therapy HIV envelope protein gp41 HIV infections antiAIDS agent clinical research drug screening /evaluation human immunodeficiency virus 1 human subject human therapy evaluation injection /infusion protein binding synthetic peptide virus infection mechanism

项目摘要

项目成果

Joseph J Eron的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to examine the safety and effectiveness (how well it works) of T-20 in the treatment of HIV infection. During this study, the subject will receive treatment with T-20 alone for ten days, and then receive T-20 along with nevirapine, nelfinavir, and saquinavir for approximately 24 weeks. Nevirapine, nelfinavir and saquinavir are approved medications that are currently available for the treatment of HIV infection by prescription from a doctor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV/AIDS Clinical Trials Unit (CTU) COVID-19 Admin Supplement
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
Clinical Core
Clinical Core